The determination of dual pancreatic and renal transplant graft vascular patency with Tc-99m HMPAO.
Combined pancreatic-renal transplants promise the restoration of physiologic control of serum glucose and normal renal function. As pancreatic transplantation becomes more common, there is an increased need for rapid, noninvasive evaluation of vascular graft patency and function. Pancreatic transplants share the renal transplant's complications of ischemia at harvest but are at greater risk. Tc-99m HMPAO is a lipophilic complex that clears rapidly from the blood after intravenous injection, and tissue accumulation is proportional to regional perfusion. Using Tc-99m HMPAO to monitor the vascular competency has the advantage of a high count rate during dynamic scintigrams but, in contrast to Tc-99m DTPA, has excellent delayed static images. Four patients who received combined cadaveric pancreatic-renal transplants and had a total of eight Tc-99m HMPAO scintigraphic examinations were reviewed.
Department of Radiology, University of California, Davis Medical Center, Sacramento.
P V
PV
Ford
M E
ME
Spieth
J M
JM
Vogel
D000328:Adult; D002102:Cadaver; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D005260:Female; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D016030:Kidney Transplantation / Q000000981:diagnostic imaging*; D008297:Male; D015609:Organotechnetium Compounds; D010091:Oximes; D016035:Pancreas Transplantation / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D051437:Renal Insufficiency / Q000601:surgery; D019690:Technetium Tc 99m Exametazime; D014654:Vascular Patency / Q000502:physiology
D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime